Hepatitis C Main Forums > Hepatitis C Research News & Studies
FDA Approves New Hep C Drug: Olysio (Simeprevir)
(1/1)
iana5252:
The U.S. Food and Drug Administration (FDA) has approved Janssen Therapeutics’ NS3/4A protease inhibitor Olysio (simeprevir) for the treatment of those with genotype 1 of hepatitis C virus (HCV) who have compensated liver disease, including cirrhosis. People who are treatment naive as well as those who have failed a previous attempt at a hep C cure may benefit from the drug, which is to be taken in combination with pegylated interferon and ribavirin.
Next up is Sovaldi (sofosbuvir). Hopefully in the next week or two.
jberlin:
They are making such great strides, and this is more welcome news, but soon I hope we will have our 1st regimen that will not include interferon. Fingers crossed. -jack